MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schmidt, K.
Right arrow Articles by Mayer, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schmidt, K.
Right arrow Articles by Mayer, B.

Vol. 59, Issue 2, 220-224, February 2001

Molecular Mechanisms Involved in the Synergistic Activation of Soluble Guanylyl Cyclase by YC-1 and Nitric Oxide in Endothelial Cells

Kurt Schmidt, Astrid Schrammel, Doris Koesling, and Bernd Mayer

Institut für Pharmakologie und Toxikologie, Karl-Franzens-Universität Graz, Graz, Austria (K.S., A.S., B.M.), and Institut für Pharmakologie und Toxikologie, Ruhr-Universität Bochum, Bochum, Germany (D.K.)

YC-1 is a direct activator of soluble guanylyl cyclase (sGC) and sensitizes the enzyme for activation by nitric oxide (NO) and CO. Because the potentiating effect of YC-1 on NO-induced cGMP formation in platelets and smooth muscle cells has been shown to be substantially higher than observed with the purified enzyme, the synergism between heme ligands and YC-1 is apparently more pronounced in intact cells than in cell-free systems. Here, we investigated the mechanisms underlying the synergistic activation of sGC by YC-1 and NO in endothelial cells. Stimulation of the cells with YC-1 enhanced cGMP accumulation up to ~100-fold. The maximal effect of YC-1 was more pronounced than that of the NO donor DEA/NO (~20-fold increase in cGMP accumulation) and markedly diminished in the presence of L-NG-nitroarginine, EGTA, or oxyhemoglobin. Because YC-1 did not activate endothelial NO synthase, the pronounced effect of YC-1 on cGMP accumulation was apparently caused by a synergistic activation of sGC by YC-1 and basal NO. The effect of YC-1 was further enhanced by addition of DEA/NO, resulting in a ~160-fold stimulation of cGMP accumulation. Thus, YC-1 increased the NO-induced accumulation of cGMP in intact cells by ~8-fold. Addition of endothelial cell homogenate increased the stimulatory effect of YC-1 on NO-activated purified sGC from 1.2- to 3.7-fold. This effect was not observed with heat-denatured homogenates, suggesting that a heat-labile factor present in endothelial cells potentiates the effect of YC-1 on NO-activated sGC.


Copyright © 2001 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
B. Roy, E. J. Halvey, and J. Garthwaite
An Enzyme-linked Receptor Mechanism for Nitric Oxide-activated Guanylyl Cyclase
J. Biol. Chem., July 4, 2008; 283(27): 18841 - 18851.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
A. E. Linder, L. P. McCluskey, K. R. Cole III, K. M. Lanning, and R. C. Webb
Dynamic Association of Nitric Oxide Downstream Signaling Molecules with Endothelial Caveolin-1 in Rat Aorta
J. Pharmacol. Exp. Ther., July 1, 2005; 314(1): 9 - 15.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
N. Balashova, F.-J. Chang, M. Lamothe, Q. Sun, and A. Beuve
Characterization of a Novel Type of Endogenous Activator of Soluble Guanylyl Cyclase
J. Biol. Chem., January 21, 2005; 280(3): 2186 - 2196.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
H.-L. Xu, V. Gavrilyuk, H. M. Wolde, V. L. Baughman, and D. A. Pelligrino
Regulation of rat pial arteriolar smooth muscle relaxation in vivo through multidrug resistance protein 5-mediated cGMP efflux
Am J Physiol Heart Circ Physiol, May 1, 2004; 286(5): H2020 - H2027.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
N. Grosser and H. Schroder
Aspirin Protects Endothelial Cells From Oxidant Damage Via the Nitric Oxide-cGMP Pathway
Arterioscler. Thromb. Vasc. Biol., August 1, 2003; 23(8): 1345 - 1351.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. V. Thorsteinsson, R. L. Kerby, H. Youn, M. Conrad, J. Serate, C. R. Staples, and G. P. Roberts
Redox-mediated Transcriptional Activation in a CooA Variant
J. Biol. Chem., July 13, 2001; 276(29): 26807 - 26813.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2001 by the American Society for Pharmacology and Experimental Therapeutics